中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
12期
73-75,76
,共4页
刘勇%罗慧贤%陈万区%苏训同%汤庆双%王刚
劉勇%囉慧賢%陳萬區%囌訓同%湯慶雙%王剛
류용%라혜현%진만구%소훈동%탕경쌍%왕강
右美托咪定%老年人%髋关节置换%镇静
右美託咪定%老年人%髖關節置換%鎮靜
우미탁미정%노년인%관관절치환%진정
Dexmedetomidine%Elderly%Total hip replacement%Sedation
目的:右美托咪定用于老年人髋关节置换术的效果观察。方法:随机选取2012年3月-2014年6月在本院行髋关节置换术的老年患者60例,并按入院的先后顺序分为A组、B组和C组,每组20例。A组患者静脉泵注4μg/mL右美托咪定10 min后,维持0.2μg/(kg·h);B组静脉泵注4μg/mL右美托咪定10 min后,维持0.4μg/(kg·h);C组静脉注射0.9%氯化钠溶液。观察并记录三组患者在麻醉前后、手术中和手术后的心率(HR)、平均动脉压(MAP)和血氧饱和度(SPO2)水平。记录三组患者的丙泊酚用量和清醒时间。同时,采用视觉模拟评分系统(VAS)对患者清醒时和手术后1 h的疼痛程度进行评分。观察患者手术后不良反应的发生率。结果:麻醉后,B组患者的SpO2水平显著低于A组和C组,差异有统计学意义(P<0.05);B组患者的丙泊酚用量低于A组和C组(P<0.05);A组患者的VAS评分低于B组和C组(P<0.05);B组患者的低氧血症发生率高于A组和C组(P<0.05)。结论:右美托咪定用于老年人髋关节置换术,镇静效果显著,对呼吸抑制较轻,不良反应少。
目的:右美託咪定用于老年人髖關節置換術的效果觀察。方法:隨機選取2012年3月-2014年6月在本院行髖關節置換術的老年患者60例,併按入院的先後順序分為A組、B組和C組,每組20例。A組患者靜脈泵註4μg/mL右美託咪定10 min後,維持0.2μg/(kg·h);B組靜脈泵註4μg/mL右美託咪定10 min後,維持0.4μg/(kg·h);C組靜脈註射0.9%氯化鈉溶液。觀察併記錄三組患者在痳醉前後、手術中和手術後的心率(HR)、平均動脈壓(MAP)和血氧飽和度(SPO2)水平。記錄三組患者的丙泊酚用量和清醒時間。同時,採用視覺模擬評分繫統(VAS)對患者清醒時和手術後1 h的疼痛程度進行評分。觀察患者手術後不良反應的髮生率。結果:痳醉後,B組患者的SpO2水平顯著低于A組和C組,差異有統計學意義(P<0.05);B組患者的丙泊酚用量低于A組和C組(P<0.05);A組患者的VAS評分低于B組和C組(P<0.05);B組患者的低氧血癥髮生率高于A組和C組(P<0.05)。結論:右美託咪定用于老年人髖關節置換術,鎮靜效果顯著,對呼吸抑製較輕,不良反應少。
목적:우미탁미정용우노년인관관절치환술적효과관찰。방법:수궤선취2012년3월-2014년6월재본원행관관절치환술적노년환자60례,병안입원적선후순서분위A조、B조화C조,매조20례。A조환자정맥빙주4μg/mL우미탁미정10 min후,유지0.2μg/(kg·h);B조정맥빙주4μg/mL우미탁미정10 min후,유지0.4μg/(kg·h);C조정맥주사0.9%록화납용액。관찰병기록삼조환자재마취전후、수술중화수술후적심솔(HR)、평균동맥압(MAP)화혈양포화도(SPO2)수평。기록삼조환자적병박분용량화청성시간。동시,채용시각모의평분계통(VAS)대환자청성시화수술후1 h적동통정도진행평분。관찰환자수술후불량반응적발생솔。결과:마취후,B조환자적SpO2수평현저저우A조화C조,차이유통계학의의(P<0.05);B조환자적병박분용량저우A조화C조(P<0.05);A조환자적VAS평분저우B조화C조(P<0.05);B조환자적저양혈증발생솔고우A조화C조(P<0.05)。결론:우미탁미정용우노년인관관절치환술,진정효과현저,대호흡억제교경,불량반응소。
Objective:To observe the clinical effect of Dexmedetomidine for elderly patients undergoing total hip replacement.Method:60 elderly patients with total hip replacement were selected and randomly divided into 3 groups, 20 cases in each group.Patients in group A received a 4 μg/mL Dexmedetomidine intravenous infusion of 10 min, maintaining 0.2 g/(kg·h); patients in group B received a 4 μg/mL Dexmedetomidine intravenous infusion of 10 min, maintaining 0.4 g/(kg·h); patients in group C received a 0.9% Sodium Chloride Solution.The heart rate (HR), mean arterial pressure (MAP) and oxygen saturation (SpO2) level of 3 groups were observed and recorded before and after anesthesia, intraoperative and postoperative.The propofol dosage and awake time of 3 groups were recorded, respectively. At the same time, pain degree was measured by using visual analogue scoring system (VAS).The incidence of adverse reaction were observed after operation.Result:After anesthesia, the patients in the B group SPO2 was significantly lower than that of A group and C group, the difference was statistically significant (P<0.05).The patients in the B group of propofol dosage is lower than that of A group and C group (P<0.05).The patients in the A group VAS were lower than those of B group and C group (P<0.05).Hypoxemia in patients in the B group were higher than A group and C group(P<0.05).Conclusion:Dexmedetomidine for elderly total hip replacement, sedative effect significantly, the respiratory inhibition is lighter and less adverse reaction.